In Situ Photoimmunotherapy: A Tumor Directed Treatment for Advanced Melanoma With Cutaneous Metastases
A novel treatment for metastatic melanoma combining a laser and an immune-system stimulating
cream with or without injection of a substance that makes the tumor more sensitive to the
laser.
Interventional
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Tolerability, safety, toxicity, of novel treatment through evaluation of subject response and physician observation of adverse events.
24 weeks
Yes
Murad Alam, MD
Principal Investigator
Northwestern University
United States: Institutional Review Board
STU1213
NCT00758797
April 2008
August 2013
Name | Location |
---|---|
Northwestern University Feinberg School of Medicine, Department of Dermatology | Chicago, Illinois 60611 |